Dillon Associates Inc Lowers stake in Stryker Corporation (SYK)

Stryker Corporation (SYK) : Dillon Associates Inc reduced its stake in Stryker Corporation by 0.11% during the most recent quarter end. The investment management company now holds a total of 104,256 shares of Stryker Corporation which is valued at $11,594,310 after selling 119 shares in Stryker Corporation , the firm said in a disclosure report filed with the SEC on May 3, 2016.Stryker Corporation makes up approximately 5.44% of Dillon Associates Inc’s portfolio.

Other Hedge Funds, Including , Harfst Associates reduced its stake in SYK by selling 20,690 shares or 90.95% in the most recent quarter. The Hedge Fund company now holds 2,060 shares of SYK which is valued at $229,093. Stryker Corporation makes up approx 0.14% of Harfst Associates’s portfolio.Polaris Greystone Financial Group boosted its stake in SYK in the latest quarter, The investment management firm added 26,636 additional shares and now holds a total of 117,166 shares of Stryker Corporation which is valued at $12,772,266. Stryker Corporation makes up approx 2.01% of Polaris Greystone Financial Group’s portfolio.Eads Heald Investment Counsel reduced its stake in SYK by selling 1,428 shares or 6.64% in the most recent quarter. The Hedge Fund company now holds 20,075 shares of SYK which is valued at $2,188,376. Stryker Corporation makes up approx 1.51% of Eads Heald Investment Counsel’s portfolio.Metlife Securities Inc boosted its stake in SYK in the latest quarter, The investment management firm added 1,755 additional shares and now holds a total of 8,594 shares of Stryker Corporation which is valued at $940,184. Stryker Corporation makes up approx 0.04% of Metlife Securities Inc’s portfolio.Van Cleef Asset Managementinc boosted its stake in SYK in the latest quarter, The investment management firm added 1,350 additional shares and now holds a total of 39,603 shares of Stryker Corporation which is valued at $4,332,568. Stryker Corporation makes up approx 1.52% of Van Cleef Asset Managementinc’s portfolio.

Stryker Corporation opened for trading at $111.38 and hit $111.91 on the upside on Tuesday, eventually ending the session at $111.75, with a gain of 0.39% or 0.43 points. The heightened volatility saw the trading volume jump to 16,69,941 shares. Company has a market cap of $41,792 M.

On the company’s financial health, Stryker Corporation reported $1.24 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Apr 20, 2016. Analyst had a consensus of $1.20. The company had revenue of $2495.00 million for the quarter, compared to analysts expectations of $2471.86 million. The company’s revenue was up 4.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.11 EPS.

Many Wall Street Analysts have commented on Stryker Corporation. Stryker Corporation was Upgraded by Sterne Agee CRT to ” Buy” on Apr 27, 2016. Company shares were Reiterated by RBC Capital Mkts on Apr 26, 2016 to “Outperform”, Firm has raised the Price Target to $ 120 from a previous price target of $108 .Company shares were Downgraded by Robert W. Baird on Apr 13, 2016 to ” Neutral”, Firm has raised the Price Target to $ 116 from a previous price target of $111 .

Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics Medical and Surgical and Neurotechnology and Spine which help improve patient and hospital outcomes.

Leave a Reply

Stryker Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on Stryker Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.